Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company ...

Abstract: Dual three-phase permanent-magnet synchronous machines (DTP-PMSM) connected with a single neutral point provide a loop for zero-sequence current (ZSC). This paper proposes a novel space ...